Cargando…
Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study
BACKGROUND: Retinopathy of prematurity (ROP) is a widely recognized cause of blindness after preterm birth. The incidence of ROP is rising especially in low- and middle-income countries (LMIC) because of improved neonatal care and increased survival of very premature neonates. To date, there is no d...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457859/ https://www.ncbi.nlm.nih.gov/pubmed/32921976 http://dx.doi.org/10.2147/OPTH.S265664 |
_version_ | 1783576082130141184 |
---|---|
author | Gezmu, Alemayehu Mekonnen Shifa, Jemal Zeberga Quinn, Graham E Nkomazana, Oathokwa Ngubula, Jinyo C Joel, Dipesalema Banda, Francis Msume Nakstad, Britt |
author_facet | Gezmu, Alemayehu Mekonnen Shifa, Jemal Zeberga Quinn, Graham E Nkomazana, Oathokwa Ngubula, Jinyo C Joel, Dipesalema Banda, Francis Msume Nakstad, Britt |
author_sort | Gezmu, Alemayehu Mekonnen |
collection | PubMed |
description | BACKGROUND: Retinopathy of prematurity (ROP) is a widely recognized cause of blindness after preterm birth. The incidence of ROP is rising especially in low- and middle-income countries (LMIC) because of improved neonatal care and increased survival of very premature neonates. To date, there is no data on incidence of ROP in Botswana. OBJECTIVE: The purpose of this study was to provide initial data and determine ROP-associated risk factors from a single neonatal care center on the incidence of ROP in Gaborone, Botswana. METHODS: A prospective observational study was conducted at Princess Marina Hospital (PMH) in Gaborone, Botswana. Premature neonates with birth weights (BW) of <1,801 g or gestational age (GA) of <34 weeks were enrolled in this study. Diagnostic examinations were conducted using an indirect ophthalmoscope with 28D lens. ROP findings were classified according to the most advanced stage of ROP reached using the International Classification of ROP (2005). Data were entered into STATA version 15 statistical software for analysis. RESULTS: There were 264 premature infants enrolled in the study. ROP screening was performed on 200 (75.8%). Of all 264 enrolled patients 133 (50.4%) were female. The mean GA was 30.3±2.6 (range 24–37) weeks and the mean BW was 1302.2±285.9 g (range 725–2035). Out of 200 who were screened, we identified 22 with ROP with a ROP incidence of 11%. The incidence of type 1 ROP (sight-threatening) was found to be 3.5%. This study identified a significant difference in possible ROP risk factors between those infants who develop ROP and those who do not, eg, BW (p<0.001), GA (p=0.024) and blood transfusion (p=0.001). CONCLUSION: This study demonstrates that ROP is a treatable cause of blindness in Botswana. Lack of a proper screening protocol, delay in diagnosis and management are plausible reasons for poor outcome in those who were diagnosed with type 1 ROP. |
format | Online Article Text |
id | pubmed-7457859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-74578592020-09-11 Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study Gezmu, Alemayehu Mekonnen Shifa, Jemal Zeberga Quinn, Graham E Nkomazana, Oathokwa Ngubula, Jinyo C Joel, Dipesalema Banda, Francis Msume Nakstad, Britt Clin Ophthalmol Original Research BACKGROUND: Retinopathy of prematurity (ROP) is a widely recognized cause of blindness after preterm birth. The incidence of ROP is rising especially in low- and middle-income countries (LMIC) because of improved neonatal care and increased survival of very premature neonates. To date, there is no data on incidence of ROP in Botswana. OBJECTIVE: The purpose of this study was to provide initial data and determine ROP-associated risk factors from a single neonatal care center on the incidence of ROP in Gaborone, Botswana. METHODS: A prospective observational study was conducted at Princess Marina Hospital (PMH) in Gaborone, Botswana. Premature neonates with birth weights (BW) of <1,801 g or gestational age (GA) of <34 weeks were enrolled in this study. Diagnostic examinations were conducted using an indirect ophthalmoscope with 28D lens. ROP findings were classified according to the most advanced stage of ROP reached using the International Classification of ROP (2005). Data were entered into STATA version 15 statistical software for analysis. RESULTS: There were 264 premature infants enrolled in the study. ROP screening was performed on 200 (75.8%). Of all 264 enrolled patients 133 (50.4%) were female. The mean GA was 30.3±2.6 (range 24–37) weeks and the mean BW was 1302.2±285.9 g (range 725–2035). Out of 200 who were screened, we identified 22 with ROP with a ROP incidence of 11%. The incidence of type 1 ROP (sight-threatening) was found to be 3.5%. This study identified a significant difference in possible ROP risk factors between those infants who develop ROP and those who do not, eg, BW (p<0.001), GA (p=0.024) and blood transfusion (p=0.001). CONCLUSION: This study demonstrates that ROP is a treatable cause of blindness in Botswana. Lack of a proper screening protocol, delay in diagnosis and management are plausible reasons for poor outcome in those who were diagnosed with type 1 ROP. Dove 2020-08-24 /pmc/articles/PMC7457859/ /pubmed/32921976 http://dx.doi.org/10.2147/OPTH.S265664 Text en © 2020 Gezmu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Gezmu, Alemayehu Mekonnen Shifa, Jemal Zeberga Quinn, Graham E Nkomazana, Oathokwa Ngubula, Jinyo C Joel, Dipesalema Banda, Francis Msume Nakstad, Britt Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title | Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title_full | Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title_fullStr | Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title_full_unstemmed | Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title_short | Incidence of Retinopathy of Prematurity in Botswana: A Prospective Observational Study |
title_sort | incidence of retinopathy of prematurity in botswana: a prospective observational study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457859/ https://www.ncbi.nlm.nih.gov/pubmed/32921976 http://dx.doi.org/10.2147/OPTH.S265664 |
work_keys_str_mv | AT gezmualemayehumekonnen incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT shifajemalzeberga incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT quinngrahame incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT nkomazanaoathokwa incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT ngubulajinyoc incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT joeldipesalema incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT bandafrancismsume incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy AT nakstadbritt incidenceofretinopathyofprematurityinbotswanaaprospectiveobservationalstudy |